Core Viewpoint - Altria Group, known for its Marlboro brand, faces an uncertain future despite its history of consistent dividend increases and dominance in the tobacco market [1][2]. Industry Transition - The tobacco industry is shifting from combustible cigarettes to smoke-free products, with Altria's ability to adapt to these trends being crucial for its long-term viability [2][5]. - The U.S. tobacco market remains lucrative, with Altria holding a 41% share of the retail cigarette market and 59.5% of the premium segment [4]. Product Development Challenges - Altria has struggled to establish itself in the next-generation product categories, including electronic vapes and heated tobacco devices, following a failed investment in Juul and a recent patent loss [5][6][7]. - Oral nicotine salt pouches have been Altria's most successful smoke-free product, but it still lags behind competitors like Philip Morris International's Zyn [8]. Financial Performance - In Q2 2025, approximately 83% of Altria's operating income came from smokeable products, indicating that smoke-free products are not yet a significant revenue source [9]. - The legacy smokeable segment remains profitable, allowing Altria to slowly increase free cash flow per share through price hikes and stock repurchases [10]. Dividend and Growth Outlook - Altria recently raised its dividend by 3.9%, offering a starting yield of 6.5%, with analysts projecting an average earnings growth of 3.4% annually over the next three to five years [11][12]. - The company is expected to maintain steady dividend growth for at least another five years, provided it can improve its performance in next-generation products [12]. Distribution Network Advantage - Altria's extensive distribution network, built through its Marlboro brand, positions it to potentially regain market share in new product categories if it executes effectively [13]. Investment Considerations - Altria is considered a strong high-yield dividend stock, appealing to investors seeking steady income, though it may not be suitable for those looking for high growth and capital gains [14][15]. - The company must enhance its product rollout and market presence in the transitioning nicotine industry to secure its long-term position [16].

Group 1 - Altria has entered into a non-binding memorandum of understanding with KT&G to expand nicotine pouches [4] - KT&G Corporation is recognized as South Korea's leading tobacco company [4] - KT&G's main business activities include the production, distribution, and sale of tobacco products [4]

Core Insights - KT&G announced growth targets and shareholder return plans during the "2025 KT&G CEO Investor Day" [1][2] - A comprehensive MOU was signed with Altria for strategic collaboration in nicotine and non-nicotine sectors [2][8] Shareholder Return Strategy - KT&G aims for a total payout ratio of 100% or higher and a dividend payout ratio of 50% or higher [3] - The minimum annual dividend per share is set at 6,000 KRW, an increase of 600 KRW from the previous year [4] - Additional share repurchase and cancellation of 260 billion KRW is planned, marking a year-on-year increase of 100 billion KRW [4] Financial Performance - The global cigarette business has achieved five consecutive quarters of "triple growth" in revenue, operating profit, and sales volume [6] - Adjusted operating profit for the first half of 2025 showed a year-on-year growth of 127.8% [6] Strategic Initiatives - KT&G targets double-digit growth for both operating profit and revenue in 2025 [8] - The MOU with Altria includes plans for joint acquisition of a Scandinavian nicotine pouch manufacturer to enter the growing nicotine pouch market [10] - Collaboration will also focus on optimizing the traditional cigarette business and expanding into the U.S. health functional foods market [12][13]

Core Viewpoint - The article highlights the attractiveness of high-yield dividend stocks, particularly during market downturns, as they provide income and potential for share-price appreciation [1][2]. Group 1: United Parcel Service (UPS) - United Parcel Service (UPS) currently offers a dividend yield of 7.8%, with shares down approximately 33% year-to-date as of September 22 [4]. - The company has faced challenges post-COVID-19, including a decline in business and reduced contracts with Amazon [5]. - There are indications of a turnaround, with CEO Carol Tomé expressing confidence in strategic initiatives aimed at improving long-term financial performance [6]. Group 2: Pfizer - Pfizer has a dividend yield of 7.2% and has experienced an 8% decline in share price over the past year [7]. - The company is navigating a post-pandemic landscape with ongoing sales of its COVID-19 vaccine and treatments, while also focusing on a robust pipeline of over 50 drug programs [8]. - Despite potential risks in the U.S. healthcare environment, Pfizer's shares appear undervalued with a forward P/E ratio of 7.7, below its five-year average [8]. Group 3: Altria Group - Altria Group offers a dividend yield of 6.5%, with a total annual payout recently at $4.12 per share, up from $3 in 2018 [9]. - The company faces challenges from declining smoking rates in the U.S. but is investing in smokeless products to offset cigarette losses [9]. - Altria's shares are considered fairly valued to somewhat overvalued, with a forward P/E ratio of 11.6, slightly above its five-year average [9].

Shenzhen, China, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Leading vaporization technology company Firstunion Group officially launched its innovative heated tobacco product—the Biheat Series—at the Inter Tabac exhibition in Germany. The product series adopts the industry’s first Dual Heating System, which maximizes the activation of tobacco components, extends single-use duration, and ensures excellent taste consistency and heating efficiency. In addition, through pioneering industry applications such as AI model ...

NIAGARA FALLS, N.Y.--(BUSINESS WIRE)---- $CABI #CABI--Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on harm-reduction products being developed under the iBlendâ"¢ brand name, today provided a corporate update in conjunction with the filing of its Semiannual Report on Form 1-SA for the first half ended June 30, 2025. First Half 2025 and Subsequent Company Highlights The Company's net loss for the six-month period in 2025 was $735,560, as compared to $299,480 for the s ...

Dividend Increase - Philip Morris International Inc. has raised its quarterly dividend by 8.9% to $1.47 per share, with the annualized dividend now totaling $5.88 per share, marking a total increase of 219.6% since 2008 [1][8] - The next dividend payment is scheduled for October 20, 2025, to shareholders on record as of October 3, 2025 [1] Growth Strategy - The company's long-term growth strategy is focused on its smoke-free transformation, with smoke-free products contributing 41% of total net revenues in Q2 2025, growing 15.2% year over year [2] - Key products driving this growth include IQOS, ZYN, and VEEV, positioning the company for sustainable growth and long-term value creation [2] Traditional Cigarette Business - Despite volume declines, the traditional cigarette business remains resilient, with combustible net revenues growing 2.1% in Q2, driven by price increases [3] - Marlboro achieved its highest quarterly market share since the 2008 spin-off, reinforcing the brand's strength and pricing leadership [3] Cost Efficiency Initiatives - The company achieved over $500 million in gross cost savings in the first half of the year through optimization initiatives, aiming for $2 billion in gross cost efficiencies between 2024 and 2026 [4] - By mid-2025, the company has already realized more than $1.2 billion in cost efficiencies, contributing to margin expansion [4] Earnings Outlook - Management has lifted its full-year adjusted earnings per share guidance to a range of $7.43-$7.56, indicating a growth of 13-15% [5] - This outlook reflects management's confidence in sustaining double-digit earnings growth despite ongoing regulatory and currency challenges [5] Stock Performance - Over the past six months, Philip Morris stock has risen 7.6%, compared to the industry's growth of 15.7% [10]

Core Insights - Altria Group, Inc. achieved 7.2% adjusted earnings per share (EPS) growth in the first half of 2025, reaching $2.67 compared to $2.49 in the same period last year, driven by higher adjusted operating companies income, fewer shares outstanding, and a lower adjusted tax rate [1][8] - The company's net revenues decreased by 3.6% year over year to $11.4 billion, primarily due to challenges in the smokeable products segment, but adjusted operating companies income for smokeable products increased by 3.5% [2][8] - Altria repurchased 10.4 million shares in the first half, contributing to EPS growth, and returned over $4 billion to shareholders through buybacks and dividends [3][8] Financial Performance - Adjusted EPS for the second quarter was $1.44, an increase of 8.3% from $1.33 in the second quarter of 2024 [1][8] - Smokeable products' adjusted operating companies income margins improved by 3.5 percentage points to 64.5%, supported by elevated pricing and cost efficiencies [2][8] - The company maintains a forward price-to-earnings ratio of 11.6X, lower than the industry's average of 14.95X [9] Comparative Analysis - Philip Morris International Inc. reported a 20.1% year-over-year increase in adjusted EPS to $1.91, benefiting from strong pricing in heated tobacco and higher volumes in smoke-free products [5] - Turning Point Brands, Inc. saw adjusted EPS rise to 98 cents, up from 89 cents last year, driven by a significant increase in Modern Oral sales [6] Future Outlook - The Zacks Consensus Estimate for Altria's earnings implies year-over-year growth of 5.3% for 2025 and 2.9% for 2026 [10]

Group 1 - British American Tobacco p.l.c. (NYSE:BTI) is recognized as one of the best high dividend stocks to buy under $100, highlighting its attractiveness to income-focused investors [1] - The company has a significant presence in the tobacco industry, bolstered by its $49 billion acquisition of Reynolds American in 2017, and offers a diverse portfolio of brands including Camel, Newport, and Vuse [2][4] - Despite efforts to transition towards next-generation products, traditional cigarettes remain the primary revenue source, with a target of generating around £5 billion (nearly $6 billion) in next-gen sales by 2025, which may be impacted by recent US regulations [3] Group 2 - British American Tobacco has consistently increased its dividend payouts since 2018, currently offering a quarterly dividend of $0.7391 per share, resulting in a dividend yield of 5.61% as of September 18 [5] - The company's global reach distinguishes it from competitors, providing broad exposure across various tobacco products, including heated tobacco and vaporizers, making it a compelling option for dividend investors [4]

Group 1: Company Performance - Broyhill Asset Management reported a 3.7% net appreciation in its Broyhill Partners fund for Q2 2025, which is lower than the MSCI All Country World Index's return of 11.7% for the same period [1] - Over the six months ending June 30, the fund achieved a return of 6.6%, compared to the index's 10.3% [1] Group 2: Philip Morris International Inc. (NYSE:PM) - Philip Morris International Inc. experienced a 16% gain in Q2 2025, driven by its smoke-free product portfolio, particularly ZYN and IQOS [3] - The stock's one-month return was -5.82%, but it appreciated by 33.92% over the past 52 weeks, closing at $161.76 on September 18, 2025, with a market capitalization of $251.794 billion [2] - Despite the stock's valuation expanding to around 20x forward earnings, it still trades below market multiples, indicating a strong growth potential in the consumer staples sector [3] - Philip Morris was held by 111 hedge fund portfolios at the end of Q2 2025, an increase from 104 in the previous quarter [4]